Information on the total number of voting rights and shares

Rhea-AI Summary

Nyxoah (NASDAQ & Euronext: NYXH) reported updated capital and voting-rights figures following new shares issued on 20 February 2026. Share capital is EUR 6,511,048.19. Total securities and voting rights: 43,662,403 ordinary shares.

The company also disclosed 3,416,319 unissued subscription rights (excluding 462,677 issued-but-ungranted rights), 225 convertible bonds (nominal EUR 91,500 each) and a potential 4,117,500 voting rights upon conversion at EUR 5.00 per share.

Key Figures

Share capital: EUR 6,511,048.19 Shares with voting rights: 43,662,403 Voting rights denominator: 43,662,403 +5 more

8 metrics

Share capital EUR 6,511,048.19 Post-issue share capital as of Feb 20, 2026

Shares with voting rights 43,662,403 Total ordinary shares carrying voting rights

Voting rights denominator 43,662,403 Total voting rights used as transparency denominator

Granted subscription rights 3,416,319 Rights to subscribe to voting shares not yet issued

Ungranted subscription rights 462,677 Subscription rights issued but not yet granted

Convertible bonds 225 Total number of outstanding convertible bonds

Bond nominal value EUR 91,500 Nominal value per convertible bond

Votes from conversion 4,117,500 Voting rights if all 225 bonds convert at EUR 5.00/share

Market Reality Check

Price: $4.70 Vol: Volume 7,064 is below the...

low vol

$4.70 Last Close

Volume Volume 7,064 is below the 20-day average of 39,275 (relative volume 0.18x). low

Technical Shares trade at $4.45, below the 200-day MA of $5.93 and closer to the 52-week low of $4.1001 than the high of $11.87.

Peers on Argus

NYXH fell 3.59% with light volume. Among close peers, moves were mixed, while sc...

1 Down

NYXH fell 3.59% with light volume. Among close peers, moves were mixed, while scanner data only flagged OSUR with a -2.5% decline, suggesting stock-specific trading rather than a broad sector move.

Common Catalyst Peer news includes company-specific events such as OraSure’s earnings release, not a unified sector catalyst.

Historical Context

5 past events · Latest: Feb 18 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 18	Middle East MoU	Positive	+8.7%	MoU to expand Genio therapy access and training in the Middle East.
Jan 21	Capacity expansion	Positive	+1.1%	Investment in Belgian manufacturing facility to support global demand.
Jan 12	Prelim 2025 results	Positive	-0.4%	Strong Q4 and FY2025 revenue growth and Q1 2026 guidance update.
Jan 12	Transparency notice	Neutral	-0.4%	Disclosure of BNP Paribas Asset Management crossing 3% voting threshold.
Dec 29	Conference presentation	Positive	+6.3%	Announcement of presentation at J.P. Morgan Healthcare Conference.

Pattern Detected

Recent operational and strategic announcements have often seen positive or modestly positive price reactions, with one divergence on strong preliminary earnings.

Recent Company History

Over the last few months, Nyxoah reported several growth-oriented developments. On Dec 29, 2025, it highlighted a J.P. Morgan Healthcare Conference presentation, followed by a transparency notification about a 3.28% shareholder on Jan 12, 2026. That same day, preliminary Q4 and FY2025 results showed strong revenue growth and cash of €47.9M. In January and February 2026, Nyxoah announced Belgian manufacturing expansion and a Middle East MoU to broaden Genio access. Today’s disclosure focuses instead on updated share capital, voting rights, and potential dilution mechanisms.

Market Pulse Summary

This announcement clarifies Nyxoah’s capital structure after new share issuance. It specifies share ...

Analysis

This announcement clarifies Nyxoah’s capital structure after new share issuance. It specifies share capital of EUR 6,511,048.19, 43,662,403 voting shares, and 3,416,319 granted subscription rights, plus 225 convertible bonds convertible into 4,117,500 voting shares at EUR 5.00. Together with recent financing activity and operational growth updates, this offers a clearer view of current and potential share count. Investors may watch future disclosures on exercises and conversions to track how the effective float evolves over time.

Key Terms

voting rights, subscription rights, convertible bonds, nominal value

4 terms

voting rights financial

"Total number of securities carrying voting rights: 43,662,403"

Voting rights are the ability of shareholders to have a say in important company decisions, like choosing leaders or approving big changes. They matter because they give owners a voice in how the company is run, similar to how voters influence elections, ensuring the company acts in shareholders’ interests.

subscription rights financial

"Number of rights to subscribe to securities carrying voting rights..."

Subscription rights are short-term privileges given to existing shareholders to buy additional new shares before the general public, typically at a set price and in proportion to their current holdings. Think of it as getting a coupon for first dibs on extra slices of a pizza so your share of the pie doesn’t shrink; exercising them can be a cheaper way to maintain your ownership and voting power, while ignoring them can reduce your stake and potential future earnings.

convertible bonds financial

"Total number of convertible bonds: 225 convertible bonds..."

A convertible bond is a loan a company issues that pays regular interest and can be exchanged for a fixed number of the company’s shares under specified terms. It matters to investors because it combines the steady income and lower downside risk of a bond with the upside potential of owning stock—like holding a ticket that can be cashed for equity if the share price rises—affecting returns, risk, and shareholder dilution.

nominal value financial

"225 convertible bonds with a nominal value of EUR 91,500 per bond"

Nominal value is the stated or face amount assigned to a financial instrument — for shares it’s the par value printed on the stock certificate, and for money or returns it can mean the number not adjusted for inflation. Think of it like a price tag on an item versus its buying power: the tag tells you the label, but not how much you can actually buy. Investors care because nominal values affect accounting, legal capital, dividend calculations and comparisons over time when inflation may distort real worth.

AI-generated analysis. Not financial advice.

REGULATED INFORMATION

Information on the total number of voting rights and shares

Mont-Saint-Guibert (Belgium), February 25, 2026, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of new shares on February 20, 2026.

• Share capital: EUR 6,511,048.19
• Total number of securities carrying voting rights: 43,662,403 (all ordinary shares)
• Total number of voting rights (= denominator): 43,662,403 (all relating to ordinary shares)
• Number of rights to subscribe to securities carrying voting rights not yet issued: 3,416,319 (all granted subscription rights; this number excludes 462,677 subscription rights that were issued but not yet granted)
• Total number of convertible bonds: 225 convertible bonds with a nominal value of EUR 91,500 per bond
• Total number of voting rights that can be obtained in case of conversion of all 225 convertible bonds at the current conversion price of EUR 5.00 per share: 4,117,500

*

* *

Contact:
Nyxoah
John Landry, CFO
IR@nyxoah.com

Attachment

• 2026 02 25 - Press release - Number of shares (ENG)

FAQ

How many total voting rights does Nyxoah (NYXH) have as of February 25, 2026?

Nyxoah has 43,662,403 total voting rights as of February 25, 2026. According to the company, all voting rights relate to ordinary shares following the February 20, 2026 share issue.

What is Nyxoah's (NYXH) reported share capital on February 25, 2026?

Nyxoah's share capital is reported as EUR 6,511,048.19. According to the company, this figure reflects the capital after the new shares issued on February 20, 2026.

How many subscription rights and ungranted rights did Nyxoah (NYXH) disclose on February 25, 2026?

Nyxoah disclosed 3,416,319 subscription rights not yet issued and excluded 462,677 issued-but-ungranted rights. According to the company, the larger number refers to granted subscription rights pending issuance.

How many additional voting rights could Nyxoah (NYXH) gain if all convertible bonds convert at EUR 5.00?

If all 225 convertible bonds convert at EUR 5.00, Nyxoah could obtain 4,117,500 additional voting rights. According to the company, each bond has a nominal value of EUR 91,500.